⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL120965 | 0.92 | SMN1; SMN2 (0.58) | — | |
| SCHEMBL28026054 | 0.92 | SMN1; SMN2 (0.58) | — | |
| SCHEMBL26697594 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL27311624 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL28257054 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL10835848 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL10412274 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL11529305 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL2360901 | 0.89 | TSHR (0.60) | — | |
| SCHEMBL26697578 | 0.89 | TSHR (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 114 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230054591-A1 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC | 2023-02-23 | — | — | US | claimed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | claimed |
| EP-2007378-B1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORP (KR) | 2016-03-30 | — | — | EP | claimed |
| EP-1565136-B1 | COMPOSITIONS FOR TRANSDERMAL OXYBUTYNIN THERAPY | WATSON PHARMACEUTICALS INC (US) | 2015-02-25 | — | — | EP | claimed |
| EP-2612629-A1 | Compositions for transdermal oxybutynin therapy | Watson Pharmaceuticals, Inc. (US) | 2013-07-10 | — | — | EP | claimed |
| EP-2544532-A2 | AGROCHEMICAL GEL COMPOSITIONS | Monsanto Technology LLC (US) | 2013-01-16 | — | — | EP | claimed |
| US-8246985-B2 | Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom | AMOREPACIFIC CORPORATION (KR) | 2012-08-21 | — | — | US | claimed |
| US-8241662-B2 | Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy | WATSON LABORATORIES, INC. (US) | 2012-08-14 | — | — | US | claimed |
| WO-2011113061-A2 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC (US) | 2011-09-15 | — | — | WO | claimed |
| US-20090068277-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORPORATION (KR) | 2009-03-12 | — | — | US | claimed |
| EP-2007378-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | Amorepacific Corporation (KR) | 2008-12-31 | — | — | EP | claimed |
| WO-2007123338-A1 | PHARMACEUTICAL COMPOSITION COMPRISING LIPASE INHIBITOR AND LIPOPHILIC OIL ABSORBENT AND ORAL FORMULATION PREPARED THEREFROM | AMOREPACIFIC CORPORATION (KR) | 2007-11-01 | — | — | WO | claimed |
| WO-2024019936-A1 | NANOMATERIALS COMPRISING TRIOLS | BEAM THERAPEUTICS INC. (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-4281050-A1 | NANOMATERIALS | Beam Therapeutics Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| CN-116761888-A | Nanomaterial for the preparation of a nanoparticle | 比姆医疗股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-11707451-B2 | Pharmaceutical composition for modified release | ASTELLAS PHARMA INC. (JP) | 2023-07-25 | — | — | US | disclosed |
| EP-0591389-B1 | DOSAGE FORM FOR A DELAYED DRUG DELIVERY | ALZA CORP (US) | 1998-04-15 | — | — | EP | disclosed |
| EP-0591389-A1 | DOSAGE FORM FOR A DELAYED DRUG DELIVERY | ALZA CORPORATION (US) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993000071-A1 | DOSAGE FORM FOR A DELAYED DRUG DELIVERY | ALZA CORPORATION (US) | 1993-01-07 | — | — | WO | disclosed |
| US-4209417-A | Perfumed particles and detergent composition containing same | THE PROCTER & GAMBLE COMPANY (US) | 1980-06-24 | — | — | US | disclosed |